Bird Flu :: 2 bird flu positive cases dead in Bali, Indonesia

AS (f, 28 years) who lived in Banjar Batu Gaing, Baraban, Kediri, Tabanan Bali died on August 21, 2007 at 01.30 p.m. at Sanglah Hospital. She was identified positive of avian influenza (AI) based on observation of Balitbangkes and Eijkman Laboratory. Therefore, there are 2 AI positive cases dead in Bali.

Bird Flu :: Indonesia send again H5N1 Virus to WHO

Indonesia has sent specimen of H5N1 virus to Centers for Disease Control and Prevention, Atlanta, (CDC Atlanta), USA, on Thursday, August 16, 2007. It is sent by National Institute of Health Research & Development (Balitbangkes) MOH through NAMRU-2 (Naval Medical Research Unit-2) USA, which is located in Balitbangkes building at Jl. Percetakan Negara, Jakarta.

Bird Flu :: Second bird flu victim confirmed from Bali, Indonesia

Test results from the Health Research and Development Center of the Ministry of Health and the Eijkman Insitute in Jakarta have confirmed that AS, a 28-year old female from Banjar Batu Gaing, Baraban, Kediri, Tabanan District in Bali is the most recent confirmed H5N1 case in Indonesia.

Bird Flu :: WHO bird flu H5N1 management guidance reinforces Tamiflu as first line treatment

The World Health Organization has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today. Experts believe that a human influenza pandemic is imminent and could be triggered by the highly pathogenic H5N1 strain, which, as of Aug. 16 2007, has infected 321 humans, causing 194 deaths worldwide.

Bird Flu :: Indonesia reports a new case of H5N1 avian influenza

The Ministry of Health of Indonesia has announced a new case of human infection of H5N1 avian influenza. A 17-year-old female from Tangerang District, in Banten Province developed symptoms on 9 August , was hospitalized on 13 August and died in hospital on 14 August.

Flu :: New target for anti-flu drug development

Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack